KRAS G12C inhibitor 18 structure
|
Common Name | KRAS G12C inhibitor 18 | ||
---|---|---|---|---|
CAS Number | 2649788-45-2 | Molecular Weight | 510.97 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H20ClFN4O3S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of KRAS G12C inhibitor 18KRAS G12C inhibitor 18 is a potent and orally active KRAS G12C inhibitor. Anti-tumor activities[1]. |
Name | KRAS G12C inhibitor 18 |
---|
Description | KRAS G12C inhibitor 18 is a potent and orally active KRAS G12C inhibitor. Anti-tumor activities[1]. |
---|---|
Related Catalog | |
Target |
KRas G12C |
In Vitro | KRAS G12C inhibitor 18 (compound 34) inhibits the growth of many KRas G12C mutant tumor cell lines (such as H358, SW1436, MiaPaca-2 cells, etc.)[1]. |
In Vivo | KRAS G12C inhibitor 18 exhibits a dose dependent inhibiton of pERK and active KRas after a single dose treatment from 12.5 to 100 mg/kg at 8 hours[1]. KRAS G12C inhibitor 18 (30 mg/kg; p.o.; twice daily) exhibits anti-tumor growth activity in lung cancer H358 xenograft mouse model[1]. |
References |
[1]. Serge Louis Boulet, et al. Kras g12c inhibitors. WO2021118877A1. |
Molecular Formula | C25H20ClFN4O3S |
---|---|
Molecular Weight | 510.97 |